Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just got to LOVE this is you're a shareholder !! And he starts this week ?
From the Dr. Kendall hiring PR -->>
"The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes," said Dr. Kendall. "Afrezza is the only inhaled fast-acting mealtime insulin on the market, and offers the right patients a flexible, safe, and effective treatment option. I'm thrilled to join MannKind, and look forward to being part of a company that has the potential to transform the lives of so many people that are living with diabetes."
Anything new on WSCC ?
tia
You never know whats ahead but I see $5+ for starters soon,in my opinion
The upside is looking real good is all I see...imo
HDVY..you may want to do some DD on this one !
HDVY..you may want to do some DD on this one !
So sounds like we coukd see a nice rise from current levels,...possibility with such a low shate structure they could do a reverse merger with a new company also?
If there is a ruling in HDVY's favor,how much $$ is possivle to be coming HDVY's way ?
No RS needed imo
I'm feeling the short squeeze of all short squeezes is coming..just a feeling with the David Kendall appointment..we shall see...all imo
Boom time !!
Yeah ..ah sure
Alot more shares then that bought imo...in just 3 days near the end of January there was about 18 million shares of volume..something more then manipulation appears to be going on imo
https://ih.advfn.com/stock-market/USOTC/health-discovery-corp-pn-HDVY/historical
MNKD..here we go..
MNKD moving up !
Don't think so imo
CHEK on fire sale here on low volume walk down...imo
CHEK on fire sale on low volume...
Imo
CHEK on fire sale here...
Imo
CHEK crazy low volume drop
He knows what MNKD will become..stay tuned...
Imo
All Aboard!!
TGLO...All Aboard !!
PMPG...watch !
imo
HDVY ,,,eom
Don't see it that way,MNKD going north of $3 anytime here imo...
Maybe..maybe more...imo
Something Big is brewing I'll bet...imo
MNKD $$
Judging by the buying I'm going with good...imo
If the company is very close to putting something out they probably don't want to say anything,got a feelin we could see something at anytime...imo
No biggie, just the spread,as soon as a filing or news drops we all know how fast this moves and that could be anytime now,this could be over .10 in the blink of a eye and .20 in 2 blinks ..all imo
Connections
Dr. Kendall’s career includes over 30 years of experience in diabetes and metabolism research, clinical management, research, and policy advocacy. Most recently, he served as Research Physician and Vice President of Global Medical Affairs for Lilly Diabetes, and during that time was responsible for all medical affairs activities and guided research and development strategy across multiple geographies. In this role, he worked to re-establish Lilly Diabetes as a world class medical organization – and added to his extensive experience with both injected and mealtime insulins, as well as devices and continuous glucose monitors. Prior to joining Eli Lilly, Dr. Kendall served as Chief Scientific and Medical Officer at the American Diabetes Association, where he was responsible for all medical affairs, medical education, research, outcomes, and medical policy activities. Earlier in his career, Dr. Kendall served as Medical Director at the International Diabetes Center, and the Park Nicollet Clinic, as well as at Amylin Pharmaceuticals. He received his M.D. and completed his Post Graduate Medical Training at the University of Minnesota, and earned a B.A. in Biology from St. Olaf College.
“The research and clinical response to Afrezza as a mealtime insulin supports ongoing efforts to establish this product as the standard of care for those living with type 1 or type 2 diabetes,” said Dr. Kendall. “Afrezza is the only inhaled fast-acting mealtime insulin on the market, and offers the right patients a flexible, safe, and effective treatment option. I’m thrilled to join MannKind, and look forward to being part of a company that has the potential to transform the lives of so many people that are living with diabetes.”
Hmmmmmmm....this might get real interesting..
A potential buyout would have nothing to do with the outstanding shares...imo...something seems to be up the way its traded here and there over the last 2 weeks,looked like some big buys,we shall see imo
PMPG !.. eom
could there be potentially a buyout of HDVY ?
David M. Kendall is gonna be a game changer imo
HDVY catching fire !